This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Boselli, E. Articles by Chassard, D. Search for Related Content PubMed PubMed Citation Articles by Boselli, E. Articles by Chassard, D. Related Collections Obstetrics Regional Anesthesia Pharmacology

---

OBSTETRIC ANESTHESIA

Ropivacaine 0.15% Plus Sufentanil 0.5 µg/mL and Ropivacaine 0.10% Plus Sufentanil 0.5 µg/mL Are Equivalent for Patient-Controlled Epidural Analgesia During Labor

Service d’Anesthésie-Réanimation, Hôtel-Dieu, Lyon, France

Address correspondence and reprint requests to Dominique Chassard, MD, PhD, Service d’Anesthésie-Réanimation, Hôtel-Dieu, 1 Place de l’Hôpital, 69288 Lyon Cedex 02, France. Address e-mail to dominique.chassard{at}chu-lyon.fr

We compared the administration of 0.15% ropivacaine plus 0.5 µg/mL of sufentanil with that of 0.10% ropivacaine plus 0.5 µg/mL of sufentanil for labor analgesia with patient-controlled epidural analgesia (PCEA) to determine whether a decreased concentration of ropivacaine could produce equally effective analgesia. One-hundred-thirty healthy pregnant women at term were randomized in a double-blinded fashion. The PCEA settings were as follows: 12-mL initial bolus, 5-mL bolus dose, 5-min lockout interval, and 10 mL/h basal infusion. Patient demographics and labor characteristics were comparable in both groups. No differences were observed for pain scores, maternal satisfaction, volume of anesthetic solution administered, number of boluses requested and delivered, need for supplemental boluses, mode of delivery, motor block, side effects, or Apgar scores. Patients in the 0.10% ropivacaine group used significantly less drug than those in the 0.15% group (mean, 57 mg; 95% confidence interval, 50.5–63.5 mg; versus mean, 88.0 mg; 95% confidence interval, 74.4–93.3 mg, respectively; P < 0.0001). Ropivacaine 0.10% plus 0.5 µg/mL of sufentanil administered via PCEA for labor analgesia is equally effective as ropivacaine 0.15% plus 0.5 µg/mL of sufentanil, with a 30% local anesthetic-sparing effect and a 40% reduction in cost. However, this reduction in local anesthetic is not associated with a decrease in the incidence of motor block, side effects, or instrumental deliveries.

IMPLICATIONS: Ropivacaine 0.10% plus 0.5 µg/mL of sufentanil given via patient-controlled epidural anesthesia for labor analgesia is equally as effective as ropivacaine 0.15% plus 0.5 µg/mL of sufentanil, with a 30% local anesthetic-sparing effect and a 40% reduction in cost. This reduction in ropivacaine concentration is not associated with a decrease in the incidence of motor block, side effects, or instrumental deliveries.

This article has been cited by other articles:

				S. H. Halpern and B. Carvalho Patient-Controlled Epidural Analgesia for Labor Anesth. Analg., March 1, 2009; 108(3): 921 - 928. [Abstract] [Full Text] [PDF]